PemiBil: Efficacy and Safety of Pemigatinib in Advanced Cholangiocarcinoma with FGFR2 Fusions/rearrangements in Real-World, Results of Multicentric French Cohort from ACABI Consortium
ANNALS OF ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要